JP2013504751A5 - - Google Patents

Download PDF

Info

Publication number
JP2013504751A5
JP2013504751A5 JP2012528391A JP2012528391A JP2013504751A5 JP 2013504751 A5 JP2013504751 A5 JP 2013504751A5 JP 2012528391 A JP2012528391 A JP 2012528391A JP 2012528391 A JP2012528391 A JP 2012528391A JP 2013504751 A5 JP2013504751 A5 JP 2013504751A5
Authority
JP
Japan
Prior art keywords
urine
ultrafiltration
collected
marker
gottingen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012528391A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013504751A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/063475 external-priority patent/WO2011029954A2/de
Publication of JP2013504751A publication Critical patent/JP2013504751A/ja
Publication of JP2013504751A5 publication Critical patent/JP2013504751A5/ja
Pending legal-status Critical Current

Links

JP2012528391A 2009-09-14 2010-09-14 血管疾患を診断および評価するためのポリペプチドマーカー Pending JP2013504751A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09170190.4 2009-09-14
EP09170190 2009-09-14
PCT/EP2010/063475 WO2011029954A2 (de) 2009-09-14 2010-09-14 Polypeptidmarker zur diagnostik und beurteilung vaskulärer erkrankungen

Publications (2)

Publication Number Publication Date
JP2013504751A JP2013504751A (ja) 2013-02-07
JP2013504751A5 true JP2013504751A5 (enExample) 2013-10-24

Family

ID=43301867

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012528391A Pending JP2013504751A (ja) 2009-09-14 2010-09-14 血管疾患を診断および評価するためのポリペプチドマーカー

Country Status (4)

Country Link
US (2) US20120241321A1 (enExample)
EP (1) EP2478377A2 (enExample)
JP (1) JP2013504751A (enExample)
WO (1) WO2011029954A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008223791B2 (en) * 2007-03-07 2013-10-03 Mosaiques Diagnostics And Therapeutics Ag Method for the standardization of the concentration of analytes in a urine sample
EP1972940A1 (de) * 2007-03-14 2008-09-24 mosaiques diagnostics and therapeutics AG Verfahren und Marker zur Diagnose von Nierenerkrankungen
US9404932B2 (en) * 2007-11-05 2016-08-02 Nordic Bioscience A/S Pathology biomarker assay
US20120037507A9 (en) * 2008-03-19 2012-02-16 Harald Mischak Method and marker for diagnosis of tubular kidney damage and illnesses
WO2010031822A1 (de) * 2008-09-17 2010-03-25 Mosaiques Diagnostics And Therapeutics Ag Nierenzellkarzinom
WO2013150132A2 (de) * 2012-04-05 2013-10-10 Mosaiques Diagnostics And Therapeutics Ag Polypeptidmarker zur diagnostik und beurteilung von schlaganfällen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1707164B1 (en) 2000-03-30 2009-11-18 Orde Levinson Urine funnelling trumpet
DE10021737C2 (de) 2000-05-04 2002-10-17 Hermann Haller Verfahren und Vorrichtung zur qualitativen und/oder quantitativen Bestimmung eines Protein- und/oder Peptidmusters einer Flüssigkeitsprobe, die dem menschlichen oder tierischen Körper entnommen wird
SG170009A1 (en) * 2005-11-30 2011-04-29 Mosaiques Diagnostics & Therap Polypeptide markers for the diagnosis and evaluation of vascular diseases
EP2479284B1 (en) * 2006-07-13 2017-09-20 University of Iowa Research Foundation Methods and reagents for treatment and diagnosis of vascular disorders and age-related macular degeneration

Similar Documents

Publication Publication Date Title
JP7598843B2 (ja) 腎疾患及び歯周疾患を検出及び診断するための方法及び組成物
JP2013504751A5 (enExample)
JP2014221801A5 (enExample)
JP2016105097A5 (enExample)
JP6325553B2 (ja) エールリヒア抗体の検出のためのペプチド、デバイス、および方法
JP2010513506A5 (enExample)
EA201070553A1 (ru) Антитела к гепцидину и варианты их применения
EA201170312A1 (ru) Селективные антитела к гепцидину-25 и их применение
Zare et al. Interaction of human serum albumin with uremic toxins: the need of new strategies aiming at uremic toxins removal
BR112013023978A2 (pt) "polipeptídeo com afinidade por proteínas de choque térmico e seu uso em diagnóstico de doença infecciosa, produção de resposta imune e tratamento 5 de câncer, bem como ácido nucleico, composição e método de fracionamento de substância para pesquisa ou análise clínica de amostra biológica".
JP2016526167A5 (enExample)
Jerman et al. OFD1 and flotillins are integral components of a ciliary signaling protein complex organized by polycystins in renal epithelia and odontoblasts
CA2793940C (en) Therapeutic use of the .beta.2m protein
Idar et al. Purification of IgY Anti-SARS-CoV-2-Chicken Nucleocapsid and elimination of its low-temperature storage-induced aggregates
Malvoisin et al. Soluble chemokine receptor CXCR4 is present in human sera
JP6583766B2 (ja) タンパク質分離方法、タンパク質分析方法、及びタンパク質分離キット
US20130259801A1 (en) Serum amyloid p protein
JP2012202966A (ja) ローヤルゼリーの品質評価方法およびローヤルゼリーの品質評価キット
WO2024258949A2 (en) Immunosorbent nanoparticles and methods of using thereof
CN101928333A (zh) 一种人eif4h多肽及其抗体制备方法
JP2013001689A (ja) 卵黄からのIgY精製方法
WO2018196011A1 (zh) Mfsd2a在制备诊断化脓性脑膜炎制品中的应用
MX2012003180A (es) Prueba de diagnóstico para enfermedades infecciosas en ganado bovino.
TWI626248B (zh) 血紅素及肌紅素之分離方法
CN117720654A (zh) 抗ngal重组抗体及其制备与应用